From: Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer
Characteristic | Extended Survival | Poor Survival |
---|---|---|
No. of patients | 10 | 10 |
Age - years | 72.0 ± 2.5 | 72.6 ± 1.6 |
Male sex - no. (%) | 8 (80) | 6 (60) |
Year of surgery - no. (%) | Â | Â |
   1992 | 1 (10) | 0 (0) |
   1994 | 0 (0) | 1 (10) |
   1999 | 9 (90) | 9 (90) |
Tumour stage - no. (%) | Â | Â |
   1 | 7 (70) | 7 (70) |
   2 | 3 (30) | 3 (30) |
Histology - no. (%) | Â | Â |
   Squamous | 8 (80) | 6 (60) |
   Adenocarcinoma | 2 (20) | 1 (10) |
   Large cell | 0 (0) | 1 (10) |
   Other | 0 (0) | 2 (20) |
Tumour Grade - no. (%) | Â | Â |
   Moderate | 4 (40) | 0 (0) |
   Poor | 6 (60) | 10 (100) |
Adjuvant Chemotherapy (%) | 0 (0) | 0 (0) |
Radiotherapy (%) | 1 (10) | 1 (10) |
Palliative Radiotherapy (%) | 1 (10) | 1 (10) |
Survival - months | 90.8 ± 11.8 | 7.9 ± 0.8 |